» Articles » PMID: 10823854

Gamma Interferon is Not Required for Mucosal Cytotoxic T-lymphocyte Responses or Heterosubtypic Immunity to Influenza A Virus Infection in Mice

Overview
Journal J Virol
Date 2000 May 24
PMID 10823854
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Heterosubtypic immunity (HSI) is defined as cross-protection against influenza virus of a different serotype than the virus initially encountered and is thought to be mediated by influenza virus-specific cytotoxic T lymphocytes (CTL). Since gamma interferon (IFN-gamma) stimulates cytotoxic cells, including antigen-specific CTL which may control virus replication by secretion of antiviral cytokines such as tumor necrosis factor alpha and IFN-gamma, we have investigated the mechanism of HSI by analyzing the role of IFN-gamma for HSI in IFN-gamma gene-deleted (IFN-gamma(-/-)) mice. It has been reported that IFN-gamma is not required for recovery from primary infection with influenza virus but is important for HSI. Here, we conclusively show that IFN-gamma is not required for induction of secondary influenza virus-specific CTL responses in mediastinal lymph nodes and HSI to lethal influenza A virus infection. Although T helper 2 (Th2)-type cytokines were upregulated in the lungs of IFN-gamma(-/-) mice after virus challenge, either Th1- or Th2-biased responses could provide heterosubtypic protection. Furthermore, titers of serum-neutralizing and cross-reactive antibodies to conserved nucleoprotein in IFN-gamma(-/-) mice did not differ significantly from those in immunocompetent mice. These results indicate that lack of IFN-gamma does not impair cross-reactive virus-specific immune responses and HSI to lethal infection with influenza virus. Our findings provide new insight for the mechanisms of HSI and should be valuable in the development of protective mucosal vaccines against variant virus strains, such as influenza and human immunodeficiency virus.

Citing Articles

NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics.

Choi Y, Saron W, ONeill A, Senanayake M, Wilder-Smith A, Rathore A J Clin Invest. 2024; 134(18).

PMID: 39088280 PMC: 11405039. DOI: 10.1172/JCI169251.


The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.

Ge T, Jhala G, Fynch S, Akazawa S, Litwak S, Pappas E Front Immunol. 2020; 11:588543.

PMID: 33343569 PMC: 7746546. DOI: 10.3389/fimmu.2020.588543.


Loss of T-bet confers survival advantage to influenza-bacterial superinfection.

Er J, Koean R, Ding J EMBO J. 2018; 38(1).

PMID: 30322895 PMC: 6315292. DOI: 10.15252/embj.201899176.


Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.

Kim M, Lee Y, Kim Y, Choi H, Kim K, Lee Y Antiviral Res. 2017; 148:43-52.

PMID: 29107058 PMC: 5699712. DOI: 10.1016/j.antiviral.2017.10.018.


IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.

Califano D, Furuya Y, Roberts S, Avram D, McKenzie A, Metzger D Mucosal Immunol. 2017; 11(1):209-219.

PMID: 28513592 PMC: 5693789. DOI: 10.1038/mi.2017.41.


References
1.
Klein J, Raulet D, Pasternack M, Bevan M . Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J Exp Med. 1982; 155(4):1198-203. PMC: 2186637. DOI: 10.1084/jem.155.4.1198. View

2.
SCHULMAN J, KILBOURNE E . INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS. J Bacteriol. 1965; 89:170-4. PMC: 315565. DOI: 10.1128/jb.89.1.170-174.1965. View

3.
Yap K, Ada G, McKenzie I . Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 1978; 273(5659):238-9. DOI: 10.1038/273238a0. View

4.
Yap K, Ada G . The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand J Immunol. 1978; 7(5):389-97. DOI: 10.1111/j.1365-3083.1978.tb00469.x. View

5.
Yetter R, Lehrer S, Ramphal R, Small Jr P . Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun. 1980; 29(2):654-62. PMC: 551177. DOI: 10.1128/iai.29.2.654-662.1980. View